dc.contributor.author | Janovec, Václav | |
dc.contributor.author | Rjabčenko, Boris | |
dc.contributor.author | Lubyová, Barbora | |
dc.contributor.author | Huerfano Meneses, Sandra | |
dc.contributor.author | Weber, Jan | |
dc.contributor.author | Hirsch, Ivan | |
dc.contributor.author | Grantz Šašková, Klára | |
dc.contributor.editor | Šímová, Šárka | |
dc.date.accessioned | 2023-11-03T13:10:39Z | |
dc.date.available | 2023-11-03T13:10:39Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14178/2067 | |
dc.description.abstract | Promyelocytic leukaemia nuclear bodies (PML-NBs) play roles in various cellular functions and represent a key component of antiviral defense. In the case of hepatitis B virus (HBV), the antiviral activity of PML-NBs has been associated with the presence of SMC5/6 and epigenetic silencing of cccDNA. However, PML-NBs can have apleiotropic effect on the life cycle of HBV and the role of PML-NBs needs to be further elucidated. | en |
dc.language.iso | en | |
dc.relation.url | http://www.ccsss.cz/index.php/ccsss/issue/view/41/ | |
dc.rights | Creative Commons Uveďte původ 4.0 International | cs |
dc.rights | Creative Commons Attribution 4.0 International | en |
dc.title | PML nuclear bodies orchestrate antiviral response in HBV-infected hepatocytes | en |
dcterms.accessRights | openAccess | |
dcterms.license | https://creativecommons.org/licenses/by/4.0/legalcode | |
dc.date.updated | 2024-01-02T10:40:44Z | |
dc.subject.keyword | PML-NBs | en |
dc.subject.keyword | HepG2-NTCP | en |
dc.relation.fundingReference | info:eu-repo/grantAgreement/MSM//LX22NPO5103 | |
dc.date.embargoStartDate | 2024-01-02 | |
dc.type.obd | 110 | |
dc.type.version | info:eu-repo/semantics/acceptedVersion | |
dc.identifier.obd | 637738 | |
dc.subject.rivPrimary | 10000::10600::10607 | |
dcterms.isPartOf.name | Czech Chemical Society Symposium Series | |
dcterms.isPartOf.issn | 2336-7202 | |
dcterms.isPartOf.journalYear | 2023 | |
dcterms.isPartOf.journalVolume | 21 | |
dcterms.isPartOf.journalIssue | 5 | |
uk.faculty.primaryId | 115 | |
uk.faculty.primaryName | Přírodovědecká fakulta | cs |
uk.faculty.primaryName | Faculty of Science | en |
uk.department.primaryId | 1034 | |
uk.department.primaryName | Katedra genetiky a mikrobiologie | cs |
uk.department.primaryName | Department of Genetics and Microbiology | en |
uk.event.name | The second annual meeting of the National Institute of Virology and Bacteriology (NIVB Meeting 2023| | |
dc.description.pageRange | 228-228 | |
dc.type.obdHierarchyCs | ABSTRAKT::abstrakt::abstrakt v konferenčním sborníku | cs |
dc.type.obdHierarchyEn | ABSTRACT::abstract::abstract in conference proceedings | en |
dc.type.obdHierarchyCode | 110::130::462 | en |
uk.displayTitle | PML nuclear bodies orchestrate antiviral response in HBV-infected hepatocytes | en |